Skip to main content
Top
Published in: World Journal of Surgery 1/2007

01-01-2007

Interleukin-10 Gene Transfer: Prevention of Multiple Organ Injury in a Murine Cecal Ligation and Puncture Model of Sepsis

Authors: Burhan Kabay, MD, Cetin Kocaefe, MD, Atac Baykal, MD, Hilmi Özden, MD, Cengiz Baycu, MD, Zafer Oner, MD, Meral Özgüç, MD, Iskender Sayek, MD

Published in: World Journal of Surgery | Issue 1/2007

Login to get access

Abstract

Introduction

The aim of this study was to determine the effect of immunoregulatory cytokine interleukin-10 (IL-10) gene therapy on multiple organ injury (MOI) induced by a cecal ligation and puncture (CLP) model of sepsis in mice.

Methods

Male Balb/c mice subjected to CLP were treated with either an hIL-10-carrying vector or an empty control vector. We assessed the degree of lung, liver, and kidney tissue destruction biochemically by measuring myeloperoxidase (MPO) and malondialdehyde (MDA) activity. Histologic assessments were based on neutrophil infiltration in lung and liver tissue. IL-10 protein expression was examined immunohistochemically, and ultrastructural changes in the liver were studied by transmission electron microscopy. We analyzed the expression of tumor necrosis factor-α (TNFα) mRNA by reverse transcription polymerase chain reaction 3, 8, and 24 hours after CLP in all organs.

Results

Organ damage was significantly reduced by hIL-10 gene transfer, which was associated at the tissue level with reduced MPO activity in the liver, lung, and kidney and decreased leukocyte sequestration and MDA formation in the lung. The liver MDA was not significantly higher in the hIL-10 gene therapy group than in the controls and seemed not to be affected by hIL-10 gene transfer. The reduced portal tract neutrophilic infiltration and preserved ultrastructure of the hepatocytes also showed that tissue function was not impaired. The lung and kidney TNFα mRNA expression was suppressed markedly in the hIL-10 gene therapy group, but liver TNFα mRNA expression varied over time.

Conclusions

These findings showed that IL-10 gene therapy significantly attenuated sepsis-induced MOI.
Literature
1.
go back to reference Natanson C. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771–783PubMed Natanson C. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994;120:771–783PubMed
2.
go back to reference Bhatia M, Moochhala S. Role of inflammatory mediatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202:145–156PubMedCrossRef Bhatia M, Moochhala S. Role of inflammatory mediatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004;202:145–156PubMedCrossRef
3.
go back to reference Poll T, Deventer SJH. Cytokines and anticytokines in the pathogenesis of sepsis. Surg Clin North Am 1999;13:413–426 Poll T, Deventer SJH. Cytokines and anticytokines in the pathogenesis of sepsis. Surg Clin North Am 1999;13:413–426
4.
go back to reference Gerard C, Bruyns C, Marchant A, et al. IL-10 reduces the release of TNF and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547–550PubMedCrossRef Gerard C, Bruyns C, Marchant A, et al. IL-10 reduces the release of TNF and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547–550PubMedCrossRef
5.
go back to reference Cassatella MA, Meda L, Bonaro S, et al. IL-10 inhibits the release of proinflammatory cytokines from human polymorphonuclear leucocytes: evidence for an autocrine role of TNF and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207–2211PubMedCrossRef Cassatella MA, Meda L, Bonaro S, et al. IL-10 inhibits the release of proinflammatory cytokines from human polymorphonuclear leucocytes: evidence for an autocrine role of TNF and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207–2211PubMedCrossRef
6.
go back to reference Marchant A, Bruyns C, Vandenabeele P, et al. IL-10 controls IFN-gamma and TNF production during experimental endotoxemia. Eur J Immunol 1994;24:1167–1171PubMed Marchant A, Bruyns C, Vandenabeele P, et al. IL-10 controls IFN-gamma and TNF production during experimental endotoxemia. Eur J Immunol 1994;24:1167–1171PubMed
7.
go back to reference De Waal Malefyt R, Abrams J, Bennet B, et al. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209–1220PubMedCrossRef De Waal Malefyt R, Abrams J, Bennet B, et al. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209–1220PubMedCrossRef
8.
go back to reference Hart PH, Hunt EK, Bonder CS, et al. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol 1996;157:3672–3680PubMed Hart PH, Hunt EK, Bonder CS, et al. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol 1996;157:3672–3680PubMed
9.
go back to reference Cassatella MA. The neutrophil: one of the cellular targets of IL-10. Int J Clin Lab Res 1998;28:148–161PubMedCrossRef Cassatella MA. The neutrophil: one of the cellular targets of IL-10. Int J Clin Lab Res 1998;28:148–161PubMedCrossRef
10.
go back to reference Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003;31:195–199CrossRef Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003;31:195–199CrossRef
11.
go back to reference Koksoy C, Kuzu A, Ergun H, et al. Role of tumour necrosis factor in lung injury caused by intestinal ischaemia-reperfusion. Br J Surg 2001;88:464–468PubMedCrossRef Koksoy C, Kuzu A, Ergun H, et al. Role of tumour necrosis factor in lung injury caused by intestinal ischaemia-reperfusion. Br J Surg 2001;88:464–468PubMedCrossRef
12.
go back to reference Cutrin JC, Boveris A, Zingaro B, et al. In situ determination by surface chemiluminescence of temporal relationships between evolving warm ischemia-reperfusion injury in rat liver and phagocyte activation and recruitment. Hepatology 2000;31:622–632PubMedCrossRef Cutrin JC, Boveris A, Zingaro B, et al. In situ determination by surface chemiluminescence of temporal relationships between evolving warm ischemia-reperfusion injury in rat liver and phagocyte activation and recruitment. Hepatology 2000;31:622–632PubMedCrossRef
13.
go back to reference Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271–278PubMedCrossRef Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271–278PubMedCrossRef
14.
go back to reference Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–275PubMed
15.
go back to reference Demling R, Nayak U, Ikegami K, et al. Comparison between lung and liver peroxidation and mortality after zymosan peritonitis in rats. Shock 1994;2:222–227PubMedCrossRef Demling R, Nayak U, Ikegami K, et al. Comparison between lung and liver peroxidation and mortality after zymosan peritonitis in rats. Shock 1994;2:222–227PubMedCrossRef
16.
go back to reference van der Poll T, Marchant A, Buurman WA, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995;155:5367–5401 van der Poll T, Marchant A, Buurman WA, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995;155:5367–5401
17.
go back to reference Latifi SQ, O’Riordan MA, Levine AD. IL-10 controls the onset of irreversible septic shock. Infect Immun 2002;70:4441–4446PubMedCrossRef Latifi SQ, O’Riordan MA, Levine AD. IL-10 controls the onset of irreversible septic shock. Infect Immun 2002;70:4441–4446PubMedCrossRef
18.
go back to reference Remick DG, Garg SJ, Newcomb DE, et al. Exogeneous IL-10 fails to decrease the mortality or morbidity of sepsis. Crit Care Med 1998;26:895–904PubMedCrossRef Remick DG, Garg SJ, Newcomb DE, et al. Exogeneous IL-10 fails to decrease the mortality or morbidity of sepsis. Crit Care Med 1998;26:895–904PubMedCrossRef
19.
go back to reference Huhn RD, Radwanski E, O’Connell SM, et al. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 1996;87:699–705PubMed Huhn RD, Radwanski E, O’Connell SM, et al. Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood 1996;87:699–705PubMed
20.
go back to reference Chernoff AE, Granowitz EV, Shapiro L, et al. A randomized controlled trial of IL-10 in humans; inhibition of inflammatory cytokine production and immune responses. J Immunol 1995;154:5492–5499PubMed Chernoff AE, Granowitz EV, Shapiro L, et al. A randomized controlled trial of IL-10 in humans; inhibition of inflammatory cytokine production and immune responses. J Immunol 1995;154:5492–5499PubMed
22.
go back to reference Chun S, Dahessia M, Lee S, et al. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy. Cell Immunol 1999;194:194–204PubMedCrossRef Chun S, Dahessia M, Lee S, et al. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: implication for gene therapy. Cell Immunol 1999;194:194–204PubMedCrossRef
23.
go back to reference Zhu N, Liggitt D, Liu Y, et al. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993;261:209–211PubMedCrossRef Zhu N, Liggitt D, Liu Y, et al. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993;261:209–211PubMedCrossRef
24.
go back to reference Simberg D, Weisman S, Talmon Y, et al. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit Rev Ther Drug Carrier Syst 2004;21:257–317PubMedCrossRef Simberg D, Weisman S, Talmon Y, et al. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit Rev Ther Drug Carrier Syst 2004;21:257–317PubMedCrossRef
25.
go back to reference Pedroso de Lima MC, Neves S, Filipe A, et al. Cationic liposomes for gene delivery: from biophysics to biological applications. Curr Med Chem 2003;10:1221–1231PubMedCrossRef Pedroso de Lima MC, Neves S, Filipe A, et al. Cationic liposomes for gene delivery: from biophysics to biological applications. Curr Med Chem 2003;10:1221–1231PubMedCrossRef
26.
go back to reference Hui KM, Ang PT, Huang L, et al. Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes. Gene Ther 1997;4:783–790PubMedCrossRef Hui KM, Ang PT, Huang L, et al. Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes. Gene Ther 1997;4:783–790PubMedCrossRef
27.
go back to reference Rini BI, Selk LM, Vogelzang NJ. Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions. Clin Cancer Res1999;5:2766–2772PubMed Rini BI, Selk LM, Vogelzang NJ. Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions. Clin Cancer Res1999;5:2766–2772PubMed
28.
go back to reference Yoshida J, Mizuno M, Wakabayashi T. Interferon beta gene therapy for cancer: basic research to clinical application. Cancer Sci 2004;95:858–865PubMedCrossRef Yoshida J, Mizuno M, Wakabayashi T. Interferon beta gene therapy for cancer: basic research to clinical application. Cancer Sci 2004;95:858–865PubMedCrossRef
29.
go back to reference Sakhuja K, Reddy PS, Ganesh S, et al. Optimization of the generation and propagation of gutless adenoviral vectors. Hum Gene Ther 2003;14:243–254PubMedCrossRef Sakhuja K, Reddy PS, Ganesh S, et al. Optimization of the generation and propagation of gutless adenoviral vectors. Hum Gene Ther 2003;14:243–254PubMedCrossRef
30.
31.
go back to reference Sayek I. Animal models for intra-abdominal infection. Hepatogastroenterology 1997;44:923–926PubMed Sayek I. Animal models for intra-abdominal infection. Hepatogastroenterology 1997;44:923–926PubMed
32.
go back to reference Takakuwa T, Endo S, Shirakura Y, et al. Interleukin–10 gene transfer improves the survival rate of mice inoculated with E. coli. Crit Care Med 2000;28:2685–2689PubMedCrossRef Takakuwa T, Endo S, Shirakura Y, et al. Interleukin–10 gene transfer improves the survival rate of mice inoculated with E. coli. Crit Care Med 2000;28:2685–2689PubMedCrossRef
33.
go back to reference Oberholzer C, Oberholzer A, Bahjat FR, et al. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci 2001;25:11503–11508CrossRef Oberholzer C, Oberholzer A, Bahjat FR, et al. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci 2001;25:11503–11508CrossRef
34.
go back to reference Zhou XM, Yagihashi A, Hirata K, et al. Downregulation of cytokine-induced neutrophil chemoattractant and prolongation of rat liver allograft survival by interleukin-10. Surg Today 1998;28:184–191CrossRef Zhou XM, Yagihashi A, Hirata K, et al. Downregulation of cytokine-induced neutrophil chemoattractant and prolongation of rat liver allograft survival by interleukin-10. Surg Today 1998;28:184–191CrossRef
35.
go back to reference Fry DE, Pearlstein L, Fulton RL, et al. Multiple system organ failure: the role of uncontrolled infection. Arch Surg 1980;115:136–140PubMed Fry DE, Pearlstein L, Fulton RL, et al. Multiple system organ failure: the role of uncontrolled infection. Arch Surg 1980;115:136–140PubMed
36.
go back to reference Armstrong L, Milla AB. Relative production of tumour necrosis factor alpha and IL-10 in adult respiratory distress syndrome. Thorax 1997;52:442–446PubMedCrossRef Armstrong L, Milla AB. Relative production of tumour necrosis factor alpha and IL-10 in adult respiratory distress syndrome. Thorax 1997;52:442–446PubMedCrossRef
37.
go back to reference Wang P, Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996;270:927–938 Wang P, Chaudry IH. Mechanism of hepatocellular dysfunction during hyperdynamic sepsis. Am J Physiol 1996;270:927–938
38.
go back to reference Ertel W, Morrison MH, Wang P, et al. The complex pattern of cytokines in sepsis: association between prostaglandins, cachectin and interleukins. Ann Surg 1991;214:141–148PubMedCrossRef Ertel W, Morrison MH, Wang P, et al. The complex pattern of cytokines in sepsis: association between prostaglandins, cachectin and interleukins. Ann Surg 1991;214:141–148PubMedCrossRef
39.
go back to reference Mayumi T, Chan CK, Clemens MG, et al. Zonal heterogeneity of hepatic injury following shock/resuscitation: relationship of xanthine oxidase activity to localization of neutrophil accumulation and central lobular necrosis. Shock 1996;5:324–332PubMedCrossRef Mayumi T, Chan CK, Clemens MG, et al. Zonal heterogeneity of hepatic injury following shock/resuscitation: relationship of xanthine oxidase activity to localization of neutrophil accumulation and central lobular necrosis. Shock 1996;5:324–332PubMedCrossRef
40.
go back to reference Zhang JX, Pegoli W Jr, Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994;266:624–632 Zhang JX, Pegoli W Jr, Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994;266:624–632
Metadata
Title
Interleukin-10 Gene Transfer: Prevention of Multiple Organ Injury in a Murine Cecal Ligation and Puncture Model of Sepsis
Authors
Burhan Kabay, MD
Cetin Kocaefe, MD
Atac Baykal, MD
Hilmi Özden, MD
Cengiz Baycu, MD
Zafer Oner, MD
Meral Özgüç, MD
Iskender Sayek, MD
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 1/2007
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-006-0066-9

Other articles of this Issue 1/2007

World Journal of Surgery 1/2007 Go to the issue